Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis.
Pollak TA, Kempton MJ, Iyegbe C, Vincent A, Irani SR, Coutinho E, Menassa DA, Jacobson L, de Haan L, Ruhrmann S, Sachs G, Riecher-Rössler A, Krebs MO, Amminger P, Glenthøj B, Barrantes-Vidal N, van Os J, Rutten BPF, Bressan RA, van der Gaag M, Yolken R, Hotopf M, Valmaggia L, Stone J, David AS; EUGEI High-Risk Study; McGuire P. Pollak TA, et al. Among authors: amminger p. Mol Psychiatry. 2021 Jun;26(6):2590-2604. doi: 10.1038/s41380-020-00899-w. Epub 2020 Oct 19. Mol Psychiatry. 2021. PMID: 33077853 Free PMC article.
Untreated initial psychosis.
McGorry PD, Harrigan SM, Amminger P, Norman R, Malla A. McGorry PD, et al. Among authors: amminger p. Am J Psychiatry. 2001 Jul;158(7):1161-3. doi: 10.1176/appi.ajp.158.7.1161-a. Am J Psychiatry. 2001. PMID: 11431249 No abstract available.
Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE, Proffitt TM, McConchie M, Kerr M, Markulev C, Yuen HP, O'Donnell C, Lubman D, Polari A, Wood S, Amminger PG, McGorry PD. Berger GE, et al. J Clin Psychiatry. 2008 Nov;69(11):1702-14. Epub 2008 Nov 18. J Clin Psychiatry. 2008. PMID: 19036233 Clinical Trial.
Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics.
Phillips LJ, Nelson B, Yuen HP, Francey SM, Simmons M, Stanford C, Ross M, Kelly D, Baker K, Conus P, Amminger P, Trumpler F, Yun Y, Lim M, McNab C, Yung AR, McGorry PD. Phillips LJ, et al. Among authors: amminger p. Aust N Z J Psychiatry. 2009 Sep;43(9):818-29. doi: 10.1080/00048670903107625. Aust N Z J Psychiatry. 2009. PMID: 19670055 Clinical Trial.
Biomarkers and clinical staging in psychiatry.
McGorry P, Keshavan M, Goldstone S, Amminger P, Allott K, Berk M, Lavoie S, Pantelis C, Yung A, Wood S, Hickie I. McGorry P, et al. Among authors: amminger p. World Psychiatry. 2014 Oct;13(3):211-23. doi: 10.1002/wps.20144. World Psychiatry. 2014. PMID: 25273285 Free PMC article.
Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
Fusar-Poli P, Cappucciati M, Borgwardt S, Woods SW, Addington J, Nelson B, Nieman DH, Stahl DR, Rutigliano G, Riecher-Rössler A, Simon AE, Mizuno M, Lee TY, Kwon JS, Lam MM, Perez J, Keri S, Amminger P, Metzler S, Kawohl W, Rössler W, Lee J, Labad J, Ziermans T, An SK, Liu CC, Woodberry KA, Braham A, Corcoran C, McGorry P, Yung AR, McGuire PK. Fusar-Poli P, et al. Among authors: amminger p. JAMA Psychiatry. 2016 Feb;73(2):113-20. doi: 10.1001/jamapsychiatry.2015.2324. JAMA Psychiatry. 2016. PMID: 26719911
46 results